P S Firby - JoVE Visualize

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Therapeutic Drug Monitoring|December 29, 2000

Determination of lovastatin in human plasma using reverse-phase high-performance liquid chromatography with UV detectionL Y Ye, P S Firby, M J Moore

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001

Pharmacological determinants of 9-aminocamptothecin cytotoxicityM L Li, L Horn, P S Firby, et al.

Cancer Research|November 21, 2000

Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivityD R Rauchwerger, P S Firby, D W Hedley, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeksL L Siu, A M Oza, E A Eisenhauer, et al.

Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Therapeutic Drug Monitoring|December 29, 2000

Determination of lovastatin in human plasma using reverse-phase high-performance liquid chromatography with UV detectionL Y Ye, P S Firby, M J Moore

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001

Pharmacological determinants of 9-aminocamptothecin cytotoxicityM L Li, L Horn, P S Firby, et al.

Cancer Research|November 21, 2000

Equilibrative-sensitive nucleoside transporter and its role in gemcitabine sensitivityD R Rauchwerger, P S Firby, D W Hedley, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 1998

Phase I and pharmacologic study of 9-aminocamptothecin colloidal dispersion formulation given as a 24-hour continuous infusion weekly times four every 5 weeksL L Siu, A M Oza, E A Eisenhauer, et al.

Pageof 1